Effect of chondroitin sulfate on intraocular pressure in rats

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5768-5775

  Belforte, Nicolás ^a   Sande, Pablo ^a   de Zavalía, Nuria ^a   Knepper, Paul A ^b   Rosenstein, Ruth E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; HISTOLOGY; INTRAOCULAR PRESSURE; MALE; MORPHOMETRICS; NERVE FIBER; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; RETINA; RETINA GANGLION CELL; TONOMETER;

ANIMALS; ANTERIOR CHAMBER; AXONS; CHONDROITIN SULFATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; INJECTIONS; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; OPTIC DISK; PHOTIC STIMULATION; RATS; RATS, WISTAR; RETINA; RETINAL GANGLION CELLS; TONOMETRY, OCULAR; VISUAL PATHWAYS;

EID: 79955666462     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5660     Document Type: Article

References (57)

1. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
2. Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci. 2003;44:3783-3789.
3. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005;24:612-637.
4. Knepper PA, Yue BYJT. Abnormal trabecular meshwork outflow. In: Levin LA, Albert DM, eds. Ocular Disease: Mechanisms and Management. Philadelphia: Saunders/Elsevier; 2010:171-177.
5. Brubaker RF. Flow of aqueous humor in humans: the Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1991;32:3145-3166.
6. Johnson M. What controls aqueous humor outflow resistance? Exp Eye Res. 2006;82:545-557.
7. Ethier CR. The inner wall of Schlemm's canal. Exp Eye Res. 2002; 74:161-172.
8. Davies JA, Fisher CE, Barnett MW. Glycosaminoglycans in the study of mammalian organ development. Biochem Soc Trans. 2001;29:166-171.
9. Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng. 2006;8:181-231.
10. Silbert JE, Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life. 2002;54:177-186.
11. Sugahara K, Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life. 2002;54:163-175.
12. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci. 2000;113:193-205.
13. Scott JE. Extracellular matrix, supramolecular organisation and shape. J Anat. 1995;187:259-269.
14. Knepper PA, Farbman AI, Telser AG. Aqueous outflow pathway glycosaminoglycans. Exp Eye Res. 1981;32:265-277.
15. Acott TS, Westcott M, Passo MS, Van Buskirk EM. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eyes. Invest Ophthalmol Vis Sci. 1985;26:1320-1329.
16. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100.
17. Johnson DH, Knepper PA. Microscale analysis of the glycosaminoglycans of human trabecular meshwork: a study in perfusion organ cultured eyes. J Glaucoma. 1994;3:58-69.
18. Knepper PA, Goossens W, Hvizd M, Palmberg PF. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1360-1367.
19. Grierson I, Lee WR. Acid mucopolysaccharides in the outflow apparatus. Exp Eye Res. 1975;21:417-431.
20. Knepper PA, McLone DG. Glycosaminoglycans and outflow pathways of the eye and brain. Pediatr Neurosci. 1985;12:240-251.
21. Gong H, Freddo TF, Johnson M. Age-related changes of sulfated proteoglycans in the normal human trabecular meshwork. Exp Eye Res. 1992;55:691-709.
22. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification in normal and primary open-angle glaucoma juxtacanalicular tissue. Invest Ophthalmol Vis Sci. 1996;37:2414-2425.
23. Barany EH. In vitro studies of the resistance to flow through the angle of the anterior chamber. Acta Soc Med Upsal. 1953;59:260-276.
24. Barany EH, Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand. 1954;30:240-248.
25. Pedler C. The relationship of hyaluronidase to aqueous outflow resistance. Trans Ophthalmol Soc UK. 1956;76:51-63.
26. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
27. Knepper PA, Farbman AI, Telser AG. Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest Ophthalmol Vis Sci. 1984;25:286-293.
28. Van Buskirk MS, Brett J. The canine eye: in vitro dissolution of the barriers to aqueous outflow. Invest Ophthalmol Vis Sci. 1978;17: 258-263.
29. Hubbard WC, Johnson M, Gong H, et al. Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp Eye Res. 1997;65:177-190.
30. Peterson WS, Jocson VL. Hyaluronidase effects on aqueous outflow resistance. Am J Ophthalmol. 1974;77:573-577.
31. Sawaguchi S, Yue B, Yeh P, Tso M. Effects of intracameral injection of chondroitinase ABC in vivo. Arch Ophthalmol. 1992;110:110-117.
32. Francois J. The importance of mucopolysaccharides in intraocular pressure. Invest Ophthalmol. 1975;14:173-176.
33. Tognetto D, Cecchini P, Ravalico G. Survey of ophthalmic viscosurgical devices. Curr Opin Ophthalmol. 2004;15:29-32.
34. Rainer G, Menapace R, Schmid KE, et al. Natural course of intraocular pressure after cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat). Ophthalmology. 2005; 112:1714-1718.
35. Arshinoff SA, Albiani DA, Taylor-Laporte J. Intraocular pressure after bilateral cataract surgery using Healon, Healon5, and Healon GV. J Cataract Refract Surg. 2002;28:617-625.
36. Keller KE, Bradley JM, Kelley MJ, Acott TS. Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture. Invest Ophthalmol Vis Sci. 2008;49:2495-2505.
37. Knepper PA, Collins JA, Frederick R. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci. 1985;26:1093-1100.
38. Knepper PA, Fadel JR, Miller AM, et al. Reconstitution of trabecular meshwork GAGs: influence of hyaluronic acid and chondroitin sulfate on flow rates. J Glaucoma. 2005;14:230-238.
39. Benozzi J, Nahum LP, Campanelli JL, Rosenstein RE. Effect of hyaluronic acid on intraocular pressure in rats. Invest Ophthalmol Vis Sci. 2002;43:2196-2200.
40. Moreno MC, Marcos HJ, Oscar Croxatto J, et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res. 2005;81:71-80.
41. Takahata K, Katsuki H, Kume T, et al. Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats. Invest Ophthalmol Vis Sci. 2003;44:1760-1766.
42. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002;43:402-410.
43. Harooni M, Freilich JM, Abelson M, Refojo M. Efficacy of hyaluronidase in reducing increases in intraocular pressure related to the use of viscoelastic substances. Arch Ophthalmol. 1998;116:1218-1221.
44. Zhu MD, Cai FY. Development of experimental chronic intraocular hypertension in the rabbit. Aust N Z J Ophthalmol. 1992;20: 225-234.
45. Bayer AU, Danias J, Brodie S, et al. Electroretinographic abnormalities in a rat glaucoma model with chronic elevated intraocular pressure. Exp Eye Res. 2001;72:667-677.
46. Bayer AU, Neuhardt T, May AC, et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1258-1265.
47. Viswanathan S, Frishman LJ, Robson JG. The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci. 2000;41:2797-2810.
48. Chauhan BC, Pan J, Archibald ML, LeVatte TL, Kelly ME, Tremblay F. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci. 2002; 43:2969-2976.
49. Papst N, Bopp M, Schnaudigel OE. Pattern electroretinogram and visually evoked cortical potentials in glaucoma. Graefes Arch Clin Exp Ophthalmol. 1984;222:29-33.
50. Towle VL, Moskowitz A, Sokol S, Schwartz B. The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate. Invest Ophthalmol Vis Sci. 1983;24:175-183.
51. Grippo TM, Hood DC, Kanadani FN, et al. A comparison between multifocal and conventional VEP latency changes secondary to glaucomatous damage. Invest Ophthalmol Vis Sci. 2006;47:5331-5336.
52. Johnson MA, Drum BA, Quigley HA, Sanchez RM, Dunkelberger GR. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci. 1989; 30:897-907.
53. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
54. Okuno T, Oku H, Sugiyama T, Yang Y, Ikeda T. Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits. Invest Ophthalmol Vis Sci. 2002;43:784-789.
55. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995;61:379-382.
56. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
57. Ueda J, Sawaguchi S, Hanyu T, et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn J Ophthalmol. 1998;42: 337-344.